Stocks
ShockWave Medical, Inc.SWAV
NASDAQHealthcareMedical Devices$334.75-0.02%
Specializing in intravascular lithotripsy technology, this medtech firm develops devices to treat calcified cardiovascular disease. Its flagship product, the Shockwave C2 Coronary IVL System, addresses a high-growth niche in interventional cardiology. Investors monitor SWAV for its disruptive approach to plaque modification and rapid revenue growth in a $10B+ addressable market.
Market Cap: $12.6B52W Range: $157.00 – $334.90
Congressional Interest in ShockWave Medical, Inc. (SWAV)
1 member of Congress has disclosed 1 trade in ShockWave Medical, Inc. (SWAV), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading SWAV?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-01-31 | Daniel Goldman | sell | $1K – $15K |